Brain-computer interface funding hits $1B in single year
Source: Financial Times (paywall)
The venture capital cascade into BCIs has accelerated dramatically—2026's funding velocity already exceeds the entire 2022-2025 period combined. Investors now view neural interfaces as investable infrastructure rather than speculative moonshot. Sustained capital at this scale forces competition on commercialization timelines and real-world applications (therapeutic, performance, accessibility), not just lab breakthroughs. Expect actual clinical deployments and product launches rather than perpetual prototype cycles over the next 18-24 months.